Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Hays, Lon R.
Farabee, David
and
Miller, Will
1998.
Caffeine and Nicotine Use in an Addicted Population.
Journal of Addictive Diseases,
Vol. 17,
Issue. 1,
p.
47.
Bennedsen, B.E.
1998.
Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors.
Schizophrenia Research,
Vol. 33,
Issue. 1-2,
p.
1.
Hughes, John R.
McHugh, Pauline
and
Holtzman, Stephen
1998.
Alcohol & Drug Abuse: Caffeine and Schizophrenia.
Psychiatric Services,
Vol. 49,
Issue. 11,
p.
1415.
Carroll, Marilyn E.
1998.
Handbook of Substance Abuse.
p.
97.
Dixon, Domeeka A
Fenix, Lori A
Kim, Denise M
and
Raffa, Robert B
1999.
Indirect Modulation of Dopamine D2 Receptors as Potential Pharmacotherapy for Schizophrenia: I. Adenosine Agonists.
Annals of Pharmacotherapy,
Vol. 33,
Issue. 4,
p.
480.
Weiss, Scott M.
Whawell, Emma
Upton, Rebecca
and
Dourish, Colin T.
2003.
Potential for antipsychotic and psychotomimetic effects of A
2A
receptor modulation
.
Neurology,
Vol. 61,
Issue. 11_suppl_6,
Casas, Miguel
Adil Qureshi, and
Prat, Gemma
and
Antoni Ramos-Quiroga, Josep
2004.
Coffee, Tea, Chocolate, and the Brain.
Vol. 20043667,
Issue. ,
Smith, Barry
Osborne, Amanda
Jones, Heather
White, Thom
and
Mann, Mark
2004.
Coffee, Tea, Chocolate, and the Brain.
Vol. 20043667,
Issue. ,
Winston, Anthony P.
Hardwick, Elizabeth
and
Jaberi, Neema
2005.
Neuropsychiatric effects of caffeine.
Advances in Psychiatric Treatment,
Vol. 11,
Issue. 6,
p.
432.
Strous, Rael
Iancu, Iulian
and
Olmer, Ahikam
2006.
Caffeine and Activation Theory.
p.
331.
Strassnig, Martin
Brar, Jaspreet S.
and
Ganguli, Rohan
2006.
Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia.
Schizophrenia Research,
Vol. 86,
Issue. 1-3,
p.
269.
Deckert, J.
Gleiter, C. H.
Schmidt, L. G.
Hüther, G.
Rüther, E.
Dietmaier, O.
and
Laux, G.
2006.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
457.
Yoshimura, Reiji
Kakihara, Shingo
Umene‐Nakano, Wakako
Sugita, Atsuko
Hori, Hikaru
Ueda, Nobuhisa
and
Nakamura, Jun
2008.
Acute risperidone treatment did not increase daily cigarette consumption or plasma levels of cotinine and caffeine: a pilot study.
Human Psychopharmacology: Clinical and Experimental,
Vol. 23,
Issue. 4,
p.
327.
Mingote, Susana
Pereira, Mariana
Farrar, Andrew M.
McLaughlin, Peter J.
and
Salamone, John D.
2008.
Systemic administration of the adenosine A2A agonist CGS 21680 induces sedation at doses that suppress lever pressing and food intake.
Pharmacology Biochemistry and Behavior,
Vol. 89,
Issue. 3,
p.
345.
Jones, Simon R.
and
Fernyhough, Charles
2009.
Caffeine, stress, and proneness to psychosis-like experiences: A preliminary investigation.
Personality and Individual Differences,
Vol. 46,
Issue. 4,
p.
562.
Ciapparelli, A.
Paggini, R.
Carmassi, C.
Taponecco, C.
Consoli, G.
Ciampa, G.
Ramacciotti, C.E.
Marazziti, D.
and
Dell’Osso, L.
2010.
Patterns of caffeine consumption in psychiatric patients. An Italian study.
European Psychiatry,
Vol. 25,
Issue. 4,
p.
230.
Tibrewal, Prashant
and
Dhillon, Rohan
2011.
Caffeine Induced Psychotic Exacerbation.
Australian & New Zealand Journal of Psychiatry,
Vol. 45,
Issue. 2,
p.
179.
Zhang, Jie
Abdallah, Chadi G.
Wang, Junqing
Wan, Xiaona
Liang, Chunlian
Jiang, Liyun
Liu, Yuzhen
Huang, Haixing
Hong, Xiaohong
Huang, Qingjun
Wu, Renhua
and
Xu, Chongtao
2012.
Upregulation of adenosine A2A receptors induced by atypical antipsychotics and its correlation with sensory gating in schizophrenia patients.
Psychiatry Research,
Vol. 200,
Issue. 2-3,
p.
126.
Rial, Daniel
Lara, Diogo R.
and
Cunha, Rodrigo A.
2014.
Adenosine Receptors in Neurology and Psychiatry.
Vol. 119,
Issue. ,
p.
395.
Topyurek, Mehmet
Tibbo, Philip
Núñez, Christian
Stephan-Otto, Christian
and
Good, Kimberley
2019.
Caffeine effects and schizophrenia: Is there a need for more research?.
Schizophrenia Research,
Vol. 211,
Issue. ,
p.
34.
eLetters
No eLetters have been published for this article.